ClinConnect ClinConnect Logo
Search / Trial NCT05607888

Prospective Study of Sinonasal and Skull-base Tumours Management

Launched by UNIVERSITY MEDICAL CENTRE LJUBLJANA · Nov 3, 2022

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying patients with tumors and diseases affecting the nose and the base of the skull. The goal is to gather information about how common these conditions are, how well different treatments work, and how they impact patients' quality of life. Researchers at a specialized center are looking to understand more about these patients by observing their cases and collecting data over time.

To participate in this study, patients should have sinonasal (nose-related) or skull-base cancer, or a sinonasal disease that is affecting the skull base. Importantly, they must also be willing to give their written consent to be part of the study. Participants can expect to be monitored by healthcare professionals, and their experiences and outcomes will contribute to a better understanding of these conditions. This research is currently in the recruiting stage and is open to all eligible patients, regardless of age or gender.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • sinonasal and/or skull-base cancer
  • sinonasal disease expanding through the skull-base
  • the patient's written informed consent
  • Exclusion Criteria:
  • lateral skull-base disease primarily originating in the temporal bone and without central skull-base involvement

About University Medical Centre Ljubljana

University Medical Centre Ljubljana (UMCL) is a leading academic medical institution in Slovenia, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMCL integrates cutting-edge medical practices with comprehensive patient care, fostering an environment of collaboration among healthcare professionals, researchers, and patients. With a strong emphasis on ethical standards and scientific integrity, UMCL aims to contribute to the global body of medical knowledge while improving treatment outcomes in various therapeutic areas.

Locations

Ljubljana, , Slovenia

Patients applied

0 patients applied

Trial Officials

Domen Vozel, MD, PhD

Study Director

University Medical Centre Ljubljana

Jure Urbančič, MD

Study Director

University Medical Centre Ljubljana

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials